Cargando…
Ventilatory support and corticosteroid therapy in SARS-CoV-2
It has been almost two years since COVID-19, a disease caused by a new coronavirus called SARS-CoV-2, was declared a pandemic by the World Health Organization. The entire scientific and medical community was put to the test during the following months to find the best therapeutic strategy to save li...
Autores principales: | Sagasti, Fernando Martínez, Blanco, Alba Palazón, García-Perrote, Sandra Catalina, Martínez, Patricia Alonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683019/ https://www.ncbi.nlm.nih.gov/pubmed/34598428 http://dx.doi.org/10.37201/req/s01.16.2021 |
Ejemplares similares
-
Thrombose und COVID-19
por: Tzaneva, Stanislava
Publicado: (2021) -
Approach to COVID-19 pandemic management in Madrid. Chronic of a year
por: Candel, Francisco Javier, et al.
Publicado: (2021) -
COVID-19: Impact on prescribing and antimicrobial resistance
por: Ruiz-Garbajosa, Patricia, et al.
Publicado: (2021) -
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020) -
Ventilation support in SARS-CoV-2 pneumonia. Strategy and indications
por: Gordo, Federico, et al.
Publicado: (2022)